These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32399906)

  • 21. Management of refractory overactive bladder.
    Giarenis I; Cardozo L
    Minerva Ginecol; 2013 Feb; 65(1):41-52. PubMed ID: 23412019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonantimuscarinic treatment for overactive bladder: a systematic review.
    Olivera CK; Meriwether K; El-Nashar S; Grimes CL; Chen CC; Orejuela F; Antosh D; Gleason J; Kim-Fine S; Wheeler T; McFadden B; Balk EM; Murphy M;
    Am J Obstet Gynecol; 2016 Jul; 215(1):34-57. PubMed ID: 26851599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond the bladder: poor sleep in women with overactive bladder syndrome.
    Savoie MB; Lee KA; Subak LL; Hernandez C; Schembri M; Fung CH; Grady D; Huang AJ
    Am J Obstet Gynecol; 2020 Jun; 222(6):600.e1-600.e13. PubMed ID: 31836545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse.
    Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL
    Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome.
    Panayi DC; Tekkis P; Fernando R; Hendricken C; Khullar V
    Neurourol Urodyn; 2010 Sep; 29(7):1295-8. PubMed ID: 20127835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of overactive bladder in women].
    Peyronnet B; Rigole H; Damphousse M; Manunta A
    Prog Urol; 2015 Nov; 25(14):877-83. PubMed ID: 26169251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actual treatment of overactive bladder and urge urinary incontinence.
    Cornu JN
    Minerva Urol Nefrol; 2013 Mar; 65(1):21-35. PubMed ID: 23538308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
    Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
    J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy.
    Ridout AE; Yoong W
    J Obstet Gynaecol; 2010 Feb; 30(2):111-4. PubMed ID: 20143965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.
    Haab F
    Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S2-5. PubMed ID: 25042138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of overactive bladder refractory to medical therapy.
    Robinson D; Giarenis I; Cardozo L
    Maturitas; 2013 May; 75(1):101-4. PubMed ID: 23415926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation enterocystoplasty in overactive bladder: is there still a role?
    Reyblat P; Ginsberg DA
    Curr Urol Rep; 2010 Nov; 11(6):432-9. PubMed ID: 20734172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Erbium YAG laser treatment in overactive bladder syndrome: a randomized controlled trial.
    Chiengthong K; Bunyavejchevin S
    Menopause; 2023 Apr; 30(4):414-420. PubMed ID: 36854167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mirabegron for overactive bladder syndrome.
    Drug Ther Bull; 2013 Aug; 51(8):90-2. PubMed ID: 23949821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe depression and anxiety in women with overactive bladder.
    Melotti IGR; Juliato CRT; Tanaka M; Riccetto CLZ
    Neurourol Urodyn; 2018 Jan; 37(1):223-228. PubMed ID: 28407347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms.
    Thomas-White K; Taege S; Limeira R; Brincat C; Joyce C; Hilt EE; Mac-Daniel L; Radek KA; Brubaker L; Mueller ER; Wolfe AJ
    Am J Obstet Gynecol; 2020 Nov; 223(5):727.e1-727.e11. PubMed ID: 32791124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
    Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of behavioral and cognitive therapy to managing overactive bladder syndrome in women in the absence of contributive urodynamic diagnosis.
    Marti BG; Valentini FA; Robain G
    Int Urogynecol J; 2015 Feb; 26(2):169-73. PubMed ID: 25377294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pelvic floor muscle training for overactive bladder symptoms - A prospective study.
    Fitz F; Sartori M; Girão MJ; Castro R
    Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1032-1038. PubMed ID: 29489983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.